Nse News

NSE Illegal Phone Tapping: ED Files Money Laundering Case, Against Former Mumbai CP

NSE Illegal Phone Tapping: ED Files Money Laundering Case, Against Former Mumbai CP

Emkay Global Bets On This Maharatna Stock For 36% Potential Gains, Details Inside

Emkay Global Bets On This Maharatna Stock For 36% Potential Gains, Details Inside

BoB Capital Suggests Buy This Mid Cap Consumer Electricals Stock For 43% Potential Upside

BoB Capital Suggests Buy This Mid Cap Consumer Electricals Stock For 43% Potential Upside

Brokerage Suggests Buy This Large-Cap Tata Stock For 21% Gains, Given Over 192% Returns In 3 Years

Brokerage Suggests Buy This Large-Cap Tata Stock For 21% Gains, Given Over 192% Returns In 3 Years

Sebi Imposes Rs 7-Crore Fine on NSE, Rs 5 Crore Each on Ramkrishna, Varanasi in 'Dark Fibre' Case

Sebi Imposes Rs 7-Crore Fine on NSE, Rs 5 Crore Each on Ramkrishna, Varanasi in 'Dark Fibre' Case

Zomato Stock Falls 6.6 Percent Post Announcement Of Blinkit Acquisition

Zomato Stock Falls 6.6 Percent Post Announcement Of Blinkit Acquisition

Brokerage Is Bullish On This Small-Cap Spec. Chemicals Stock, Suggest Buy For Robust 79% Gains

Brokerage Is Bullish On This Small-Cap Spec. Chemicals Stock, Suggest Buy For Robust 79% Gains

Buy Large Cap Pharma Stock For Over 40 Gains, Sees 24% Earnings CAGR, Stock Near 52 Week Low

Buy Large Cap Pharma Stock For Over 40 Gains, Sees 24% Earnings CAGR, Stock Near 52 Week Low

India's Largest CGD Company Hit 52-Week Low, Brokerage Suggest Buy For Robust 60% Gains

India's Largest CGD Company Hit 52-Week Low, Brokerage Suggest Buy For Robust 60% Gains

CBI arrests OPG Securities MD Sanjay Gupta In NSE Co-Location Scam

CBI arrests OPG Securities MD Sanjay Gupta In NSE Co-Location Scam

Buy This Medical Equipment Stock For 40% Gains, Recorded Sector-Leading 51% EBITDA Margins

Buy This Medical Equipment Stock For 40% Gains, Recorded Sector-Leading 51% EBITDA Margins

Better Operating Performance Than Other PSBs, Buy BoB For Target Price Of Rs.120: Edelweiss

Better Operating Performance Than Other PSBs, Buy BoB For Target Price Of Rs.120: Edelweiss

5 Pharma Stocks Down More Than 70% From Their 52 Week High Levels

5 Pharma Stocks Down More Than 70% From Their 52 Week High Levels

Prabhudas Lilladher Gives Buy Rating To This Stock For Strong 28% Upside

Prabhudas Lilladher Gives Buy Rating To This Stock For Strong 28% Upside

Buy This IT Stock For 16% Gains, Given Over 450% Returns In 5 Years, Reported 25% Revenue Growth

Buy This IT Stock For 16% Gains, Given Over 450% Returns In 5 Years, Reported 25% Revenue Growth

LIC Shares Hit All Time Low Level; Factors That Triggered Fall Of 18% Since IPO Listing

LIC Shares Hit All Time Low Level; Factors That Triggered Fall Of 18% Since IPO Listing

2 Good Stocks Near Their 52-Week Low, Good Time To Buy?

2 Good Stocks Near Their 52-Week Low, Good Time To Buy?

Buy This Stock Today To Get A Potential Return of 47%, Declared Highest Q4 Revenue

Buy This Stock Today To Get A Potential Return of 47%, Declared Highest Q4 Revenue

Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
  • Block for 8 hours
  • Block for 12 hours
  • Block for 24 hours
  • Don't block
Gender
Select your Gender
  • Male
  • Female
  • Others
Age
Select your Age Range
  • Under 18
  • 18 to 25
  • 26 to 35
  • 36 to 45
  • 45 to 55
  • 55+